Limin Zhang

Limin Zhang

Auto-generated profile, based on publicly available information

Limin Zhang

Department of Urology, Huashan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
GTGreeshma Thrivikraman
Greeshma Thrivikraman
AAAvathamsa Athirasala
Avathamsa Athirasala
RGRyan Gordon
Ryan Gordon
LZLimin Zhang
Limin Zhang
RBRaymond Bergan
Raymond Bergan
Luiz BertassoniLuiz Bertassoni
Luiz Bertassoni
Bone tissue, by definition, is an organic–inorganic nanocomposite, where metabolically active cells are embedded within a matrix that is heavily calcified on the nanoscale. Currently, there are no strategies that replicate these definitive characteristics of bone tissue. Here we describe a biomimetic approach where a supersaturated calcium and phosphate medium is used in combination with a non-collagenous protein analog to direct the deposition of nanoscale apatite, both in the intra- and extrafibrillar spaces of collagen embedded with osteoprogenitor, vascular, and neural cells. This process enables engineering of bone models replicating the key hallmarks of the bone cellular and extracellular microenvironment, including its protein-guided biomineralization, nanostructure, vasculature, innervation, inherent osteoinductive properties (without exogenous supplements), and cell-homing effects on bone-targeting diseases, such as prostate cancer. Ultimately, this approach enables fabrication of bone-like tissue models with high levels of biomimicry that may have broad implications for disease modeling, drug discovery, and regenerative engineering.

14 January 2022 in Molecular Therapy
Verified
Journal Article
Open access
CYChen Yang
Chen Yang
SWSiqi Wu
Siqi Wu
ZMZezhong Mou
Zezhong Mou
QZQuan Zhou
Quan Zhou
XDXiyu Dai
Xiyu Dai
HJHaowen Jiang
Haowen Jiang
Circular RNAs (circRNAs) play critical roles in different diseases. Exosomes are important intermediates of intercellular communication. While both have been widely reported in cancers, exosome-derived circRNAs are rarely studied. In this work, we identified the differently expressed circRNAs in bladder cancer (BCa) tissue and exosomes through high-throughput sequencing. RNA pull-down, RNA immunoprecipitation, and luciferase reporter assays were used to investigate the interactions between specific circRNAs, microRNAs (miRNAs), and mRNAs. Wound-healing, Transwell, Cell Counting Kit-8 (CCK8), and colony-formation assays were used to study the biological roles in vitro. Metabolomics were used to explore the mechanism of how specific circRNAs influenced BCa cell behavior. Flow cytometry was used to study how specific circRNAs affected the function of CD8+ T cells in tumor microenvironments. We identified that exosome-derived hsa_circ_0085361 (circTRPS1) was correlated with aggressive phenotypes of BCa cells via sponging miR-141-3p. Metabolomics and RNA sequencing (RNA-seq) identified GLS1-mediated glutamine metabolism was involved in circTRPS1-mediated alterations. Exosomes derived from circTRPS1 knocked down BCa cells, prevented CD8+ T cells from exhaustion, and repressed the malignant phenotype of BCa cells. In conclusion, exosome-derived circTRPS1 from BCa cells can modulate the intracellular reactive oxygen species (ROS) balance and CD8+ T cell exhaustion via the circTRPS1/miR141-3p/GLS1 axis. Our work may provide a potential biomarker and therapeutic target for BCa.

27 June 2023 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
YYYifei Yan
Yifei Yan
RLRongzong Liu
Rongzong Liu
HCHaobo Chen
Haobo Chen
LZLimin Zhang
Limin Zhang
QZQi Zhang
Qi Zhang
The accurate segmentation of prostate region in magnetic resonance imaging (MRI) can provide reliable basis for artificially intelligent diagnosis of prostate cancer. Transformer-based models have been increasingly used in image analysis due to their ability to acquire long-term global contextual features. Although Transformer can provide feature representations of the overall appearance and contour representations at long distance, it does not perform well on small-scale datasets of prostate MRI due to its insensitivity to local variation such as the heterogeneity of the grayscale intensities in the peripheral zone and transition zone across patients; meanwhile, the convolutional neural network (CNN) could retain these local features well. Therefore, a robust prostate segmentation model that can aggregate the characteristics of CNN and Transformer is desired. In this work, a U-shaped network based on the convolution coupled Transformer is proposed for segmentation of peripheral and transition zones in prostate MRI, named the convolution coupled Transformer U-Net (CCT-Unet). The convolutional embedding block is first designed for encoding high-resolution input to retain the edge detail of the image. Then the convolution coupled Transformer block is proposed to enhance the ability of local feature extraction and capture long-term correlation that encompass anatomical information. The feature conversion module is also proposed to alleviate the semantic gap in the process of jumping connection. Extensive experiments have been conducted to compare our CCT-Unet with several state-of-the-art methods on both the ProstateX open dataset and the self-bulit Huashan dataset, and the results have consistently shown the accuracy and robustness of our CCT-Unet in MRI prostate segmentation. The codes are available at https://github.com/git-yan/CCT-Unet .

15 August 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
CYChen Yang
Chen Yang
YOYuxi Ou
Yuxi Ou
QZQuan Zhou
Quan Zhou
YLYingchun Liang
Yingchun Liang
WLWeijian Li
Weijian Li
HJHaowen Jiang
Haowen Jiang
Metabolism vulnerability of cisplatin resistance in BCa cells remains to be discovered, which we applied integrated multi-omics analysis to elucidate the metabolism related regulation mechanism in bladder cancer (BCa) microenvironment. Integrated multi-omics analysis of metabolomics and proteomics revealed that MAT2A regulated methionine metabolism contributes to cisplatin resistance in BCa cells. We further validated MAT2A and cancer stem cell markers were up-regulated and circARHGAP10 was down-regulated through the regulation of MAT2A protein stability in cisplatin resistant BCa cells. circARHGAP10 formed a complex with MAT2A and TRIM25 to accelerate the degradation of MAT2A through ubiquitin-proteasome pathway. Knockdown of MAT2A through overexpression of circARHGAP10 and restriction of methionine up-take was sufficient to overcome cisplatin resistance in vivo in immuno-deficiency model but not in immuno-competent model. Tumor-infiltrating CD8+ T cells characterized an exhausted phenotype in tumors with low methionine. High expression of SLC7A6 in BCa negatively correlated with expression of CD8. Synergistic inhibition of MAT2A and SLC7A6 could overcome cisplatin resistance in immuno-competent model in vivo. Cisplatin resistant BCa cells rely on methionine for survival and stem cell renewal. circARHGAP10/TRIM25/MAT2A regulation pathway plays an important role in cisplatin resistant BCa cells while circARHGAP10 and SLC7A6 should be evaluated as one of the therapeutic target of cisplatin resistant BCa.

25 February 2023 in Epigenetics
Verified
Journal Article
Open access
XDXiyu Dai
Xiyu Dai
XCXinan Chen
Xinan Chen
WCWensun Chen
Wensun Chen
YOYuxi Ou
Yuxi Ou
YCYiling Chen
Yiling Chen
HJHaowen Jiang
Haowen Jiang
Prostate cancer is the most prevalent type of cancer among men worldwide. The importance of circular RNA (circRNA) in prostate cancer and its connection to malignancy has been steadily recognized. circRNA expression was obtained by circRNA sequencing of prostate cancer. circRNA and its function were further analysed. The results were verified by qRT-PCR, RIP assay, FISH, RNA pulldown, WB, CCK-8, colony formation assay and wound-healing assay. BALB/c Nude mice were used for xenograft hosts. Low expression of circDHRS3 was assessed in prostate cancer. Overexpression of circDHRS3 inhibited prostate cancer growth and migration in vitro. Additionally, miR-421 was shown to be the downstream target of circDHRS3, as shown by fluorescence in situ hybridization and dual-luciferase experiments. The rescue assay results for the PC3 and Du145 cell lines demonstrated that circDHRS3 inhibits prostate cancer cell lines’ ability to proliferate and metastasize by modulating MEIS2 expression through the circDHRS3/miR-421/MEIS2 axis. In vivo investigations confirmed that the overexpression of circDHRS3 could inhibit both the lung and bone metastasis of prostate cancer cells. circDHRS3 has the potential to become a biomarker and a targeted therapeutic site for prostate cancer, particularly in the malignant stage. Our study indicates that circDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis.

6 September 2022 in Cancer Science
Verified
Journal Article
Open access
QZQuan Zhou
Quan Zhou
CYChen Yang
Chen Yang
ZMZezhong Mou
Zezhong Mou
SWSiqi Wu
Siqi Wu
XDXiyu Dai
Xiyu Dai
HJHaowen Jiang
Haowen Jiang
Recent studies identified Midkine (MDK) as playing a key role in immune regulation. In this study, we aimed to discover the clinical significance and translational relevance in prostate cancer (PCa). We retrospectively analyzed 759 PCa patients who underwent radical prostatectomy from Huashan Hospital, Fudan University (training cohort, n = 369) and Chinese Prostate Cancer Consortium (validation cohort, n = 390). A total of 325 PCa patients from The Cancer Genome Atlas (TCGA) database (external cohort) were analyzed for exploration. Immune landscape and antitumor immunity were assessed through immunohistochemistry and flow cytometry. Patient‐derived explant culture system was applied for evaluating the targeting potential of MDK. We found that intratumoral MDK expression correlated with PCa progression, which indicated an unfavorable biochemical recurrence (BCR)‐free survival for postoperative PCa patients. Addition of MDK expression to the postoperative risk assessment tool CAPRA‐S could improve its prognostic value. Tumors with MDK abundance characterized the tumor‐infiltrating CD8+ T cells with less cytotoxicity production and increased immune checkpoint expression, which were accompanied by enriched immunosuppressive contexture. Moreover, MDK inhibition could reactivate CD8+ T cell antitumor immunity. MDK mRNA expression negatively correlated with androgen receptor activity signature and positively associated with radiotherapy‐related signature. In conclusion, intratumoral MDK expression could serve as an independent prognosticator for BCR in postoperative PCa patients. MDK expression impaired the antitumor function of CD8+ T cells through orchestrating an immunoevasive microenvironment, which could be reversed by MDK inhibition. Moreover, tumors with MDK enrichment possessed potential sensitivity to postoperative radiotherapy while resistance to adjuvant hormonal therapy of PCa. MDK could be considered as a potential therapeutic target for PCa.